Erste Asset Management’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-375,000
| Closed | -$38.1M | – | 624 |
|
|
2025
Q4 | $38.1M | Sell |
375,000
-20,900
| -5% | -$1.68M | 0.32% | 77 |
|
|
2025
Q3 | $21.1M | Sell |
395,900
-40,423
| -9% | -$2.02M | 0.2% | 119 |
|
|
2025
Q2 | $23.2M | Buy |
436,323
+1,051
| +0.2% | +$53.4K | 0.2% | 111 |
|
|
2025
Q1 | $18.9M | Buy |
435,272
+82,491
| +23% | +$4.18M | 0.24% | 100 |
|
|
2024
Q4 | $19.9M | Sell |
352,781
-39,358
| -10% | -$2.45M | 0.24% | 101 |
|
|
2024
Q3 | $26.5M | Buy |
392,139
+86,007
| +28% | +$4.85M | 0.32% | 82 |
|
|
2024
Q2 | $13M | Sell |
306,132
-17,796
| -5% | -$979K | 0.17% | 133 |
|
|
2024
Q1 | $22.3M | Buy |
323,928
+41,000
| +14% | +$2.59M | 0.3% | 94 |
|
|
2023
Q4 | $21M | Buy |
282,928
+25,000
| +10% | +$1.64M | 0.31% | 94 |
|
|
2023
Q3 | $17.6M | Sell |
257,928
-14,862
| -5% | -$1.26M | 0.3% | 96 |
|
|
2023
Q2 | $25.6M | Sell |
272,790
-35,212
| -11% | -$2.75M | 0.45% | 68 |
|
|
2023
Q1 | $20.8M | Sell |
308,002
-50,876
| -14% | -$3.27M | 0.4% | 74 |
|
|
2022
Q4 | $17.8M | Buy |
358,878
+35,905
| +11% | +$1.47M | 0.38% | 75 |
|
|
2022
Q3 | $10.5M | Buy |
322,973
+33,026
| +11% | +$1.36M | 0.24% | 122 |
|
|
2022
Q2 | $11.5M | Buy |
289,947
+106,447
| +58% | +$5.69M | 0.26% | 111 |
|
|
2022
Q1 | $12.9M | Sell |
183,500
-38,400
| -17% | -$2.81M | 0.25% | 109 |
|
|
2021
Q4 | $17.2M | Buy |
221,900
+66,000
| +42% | +$5.82M | 0.31% | 95 |
|
|
2021
Q3 | $14.8M | Buy |
155,900
+45,000
| +41% | +$4.75M | 0.29% | 100 |
|
|
2021
Q2 | $13.9M | Buy |
110,900
+15,000
| +16% | +$1.79M | 0.28% | 109 |
|
|
2021
Q1 | $12.5M | Sell |
95,900
-38,000
| -28% | -$5.2M | 0.31% | 101 |
|
|
2020
Q4 | $18.1M | Sell |
133,900
-11,400
| -8% | -$1.38M | 0.5% | 55 |
|
|
2020
Q3 | $14.8M | Buy |
145,300
+25,000
| +21% | +$2.16M | 0.51% | 65 |
|
|
2020
Q2 | $10.4M | Hold |
120,300
| – | – | 0.42% | 78 |
|
|
2020
Q1 | $6.99M | Buy |
120,300
+54,000
| +81% | +$4.38M | 0.41% | 68 |
|
|
2019
Q4 | $6.17M | Sell |
66,300
-33,500
| -34% | -$2.95M | 0.27% | 92 |
|
|
2019
Q3 | $9.1M | Sell |
99,800
-12,000
| -11% | -$1.37M | 0.49% | 55 |
|
|
2019
Q2 | $13M | Hold |
111,800
| – | – | 0.69% | 34 |
|
|
2019
Q1 | $9.58M | Buy |
111,800
+5,000
| +5% | +$426K | 0.54% | 41 |
|
|
2018
Q4 | $6.51M | Buy |
+106,800
| New | +$7.33M | 0.44% | 53 |
|
Other funds holding EXAS
PRS
PWMAG
IA
HNB
BC
Erste Asset Management's EXAS Position: Q1 2026 in Review
Erste Asset Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 375,000 shares — an estimated $38.1M sold.
Erste Asset Management first reported a position in EXAS in Q4 2018 and held it in 29 quarters. The position peaked at $38.1M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.
- Erste Asset Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
- Erste Asset Management sold 375,000 Exact Sciences shares in Q1 2026, an estimated $38.1M.
- Erste Asset Management first reported a position in Exact Sciences in Q4 2018 and held it in 29 quarters.
- Erste Asset Management's Exact Sciences position peaked at $38.1M in Q4 2025.
- 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.
Based on Erste Asset Management's 13F filing for Q1 2026, filed 11 May 2026.